---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-022449"
form_type: "8-K"
ticker: "CADL"
cik: "0001841387"
company_name: "Candel Therapeutics, Inc."
filed_at: "2022-01-31T23:59:59+00:00"
generated_at: "2026-06-27T13:43:48.350813+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Candel Therapeutics removes Estuardo Aguilar-Cordova and Laura Aguilar as officers effective Feb 7, 2022

## Summary
- Estuardo Aguilar-Cordova and Laura Aguilar terminated without cause as officers, effective February 7, 2022.
- Estuardo Aguilar-Cordova will remain on the Board of Directors.
- Both will receive severance as per employment agreements, subject to release of claims.

## SEC filing metadata
- accession: 0001193125-22-022449
- form_type: 8-K
- ticker: CADL
- cik: 0001841387
- company_name: Candel Therapeutics, Inc.
- filed_at: 2022-01-31T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841387/000119312522022449/0001193125-22-022449-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841387/000119312522022449/d292852d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-022449
- JSON: https://secwatch.observer/filing/0001193125-22-022449.json
- Plain text: https://secwatch.observer/filing/0001193125-22-022449.txt

## Key facts
- Executive change
  Laura Aguilar was removed as officer at Candel Therapeutics, Inc..
  - Action: removed
  - Role: officer
  source text: On January 28, 2022, Candel Therapeutics, Inc. (the “Company”) removed Estuardo Aguilar-Cordova and Laura Aguilar from their roles as officers of the Company, without cause under their respective employment agreements with the Company, with such termination expected to be effective on February 7, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312522022449/0001193125-22-022449-index.htm
- Executive change
  Estuardo Aguilar-Cordova was removed as officer at Candel Therapeutics, Inc..
  - Action: removed
  - Role: officer
  source text: On January 28, 2022, Candel Therapeutics, Inc. (the “Company”) removed Estuardo Aguilar-Cordova and Laura Aguilar from their roles as officers of the Company, without cause under their respective employment agreements with the Company, with such termination expected to be effective on February 7, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312522022449/0001193125-22-022449-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.